Drylab AI Raised $3 Million in Seed Funding
The biotech startup secured fresh capital to expand its workforce and pursue security certifications for research.
Updated on Oct. 13, 2026 in Biotech
Live Poll
Do you trust autonomous AI agents to conduct scientific research accurately and reliably?
Drylab AI has secured $3 million in a seed funding round led by Vertex Ventures with participation from PatSnap. The startup plans to utilize the capital to grow its engineering, biology, and sales teams.
Why it matters
The company aims to enhance its autonomous research platform and obtain necessary security and compliance certifications for large research organizations. This funding positions the firm to better serve its international customer base across the US, Europe, and Asia.
The Drylab AI platform integrates more than 800 distinct scientific tools and databases. Its autonomous agents refine experimental work by learning from previous scientific analysis runs.
The players
Drylab AI
A Singapore-based biotech company that provides autonomous research agents for scientific environments.
Vertex Ventures
A global venture capital firm that led the recent seed funding round for Drylab AI.
PatSnap
A connected innovation intelligence company that participated as an investor in the seed round.
The details
The platform, which launched earlier this year, provides autonomous agents that select and utilize integrated scientific tools to perform research tasks. By automating complex laboratory workflows, the company seeks to scale its capabilities for enterprise clients.
Timeline
Drylab AI launched its platform in February 2026.
The seed funding round was announced on October 13, 2026.
The Tech Race
The emergence of autonomous research agents is shifting how biotech firms scale R&D processes. Drylab AI is positioning itself within this competitive landscape by replacing manual laboratory workflows with automated, data-driven systems.
As the startup expands its team and security certifications, research organizations using the platform may experience improved software stability and compliance standards. Future updates could also result in the integration of additional scientific databases to streamline workflows.
The takeaway
Autonomous research agents are increasingly being adopted to reduce human error and accelerate experimental timelines. Biotech startups like Drylab AI are setting a new standard for integration by connecting hundreds of databases into a single interface.
Further reading
For more information on the evolving laboratory software landscape, visit the Biotech section.
Source note: This article includes information reported by The Business Times.
Live Poll
Do you trust autonomous AI agents to conduct scientific research accurately and reliably?
